A subdermal collagen regeneration filler with 3% high-purity atelo collagen, featuring patented telopeptide-removal technology (99.8% antigenicity reduction). Clinically validated for sustained collagen synthesis (6-12 month duration) and 87% fibroblast activation rate. FDA-cleared for facial contouring and wrinkle reduction in deep dermis/subcutaneous layers.

Key Advantages

Innovative Technology

• Telopeptide cleavage via JDBIO-3D Matrix Tech®
• Non-crosslinked triple helix structure (≥98% integrity)
• ISO 10993 biocompatibility certified

Packaging Specifications

• 1.0ml/pre-filled syringe
• 30G×2 sterile needles
• 24-month shelf life at 2-8°C

Clinical Protocol

1. Strict cold chain maintenance (2-8°C)
2. Layered injection with 30G needle (0.5-1.0ml/session)
3. Post-treatment cooling protocol
4. Maintenance every 6-12 months

*Individual results may vary: Collagen metabolism rates differ by 18-35% depending on age and skin condition. Not recommended for patients with autoimmune disorders.